
Accelerating Research with Predictive Human Bioassays and 3D Models
CTI Pharma, Innovative Drug Development
Accelerating cancer and human disease research with advanced predictive bioassays and 3D tissue models for better outcomes.
R&D testing and innovation research
We carry out testing of devices, drugs, plastics, vaccines and other components for pharmaceutical, biotech, hospitals and universities. Comprehensive R&D services for drug testing and medical device co-development tailored to your needs.
But we also carry out innovation projects over the longer term by cooperation.


Bioassay Co-Creation
Often clients have specific needs. We are happy to discuss these with you and create a collaborative bioassay design utilizing patient-specific models to enhance efficacy and speed up trials. We have done this in cancer, immunology, and disease specific pathologies.
Contact us for more details.


Publications
Some of our recent pharma related publications can be seen here:
2025, Stable Biotherapeutic Penetration Screening in Critically Small Colorectal Metastatic Cancer Biopsies Allows for Oncolytic Virus-Delivered Chemotherapeutic Response Assessment through 3D Bioprinted Organoid Expansion, Publisher Link
2023, World's First Long-Term Colorectal Cancer Model by 3D Bioprinting as a Mechanism for Screening Oncolytic Viruses, Pubmed
2022, Engineering of a Microscale Niche for Pancreatic Tumor Cells Using Bioactive Film Coatings Combined with 3D-Architectured Scaffolds, Pubmed
2021, A Colorectal Cancer 3D Bioprinting Workflow as a Platform for Disease Modeling and Chemotherapeutic Screening, Pubmed
Innovative Solutions
Accelerating drug development through advanced predictive bioassays


Clinical Trial Support
Enhancing efficacy with patient-derived 3D tissue models.


Research Collaboration
Partnering for drug testing and medical device development.




Bioassay Development
Creating tailored bioassays for specific research needs.
Open Lab
Providing access to advanced research facilities and expertise.
Certifications
We operate to the highest standards internationally. We are fully authorized to work with human tissues and recognized as a fast-growing company "PERL" by the French government.
Our French laboratory is certified ISO 9001 : 2015.





Get In Touch
CTIBIOTECH Europe
Bat A16, 5 avenue Lionel Terray
69330 Meyzieu
Lyon, France
office@ctibiotech.com
Subscribe to our newsletter



CTIBIOTECH USA
601 Walnut Street, Suite 825
Philadelphia, PA, 19106
USA
office@ctibiotech.com